Jingjing Sun

3.5k total citations · 1 hit paper
75 papers, 2.7k citations indexed

About

Jingjing Sun is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Jingjing Sun has authored 75 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Biomedical Engineering, 28 papers in Molecular Biology and 19 papers in Biomaterials. Recurrent topics in Jingjing Sun's work include Nanoplatforms for cancer theranostics (20 papers), Nanoparticle-Based Drug Delivery (17 papers) and RNA Interference and Gene Delivery (12 papers). Jingjing Sun is often cited by papers focused on Nanoplatforms for cancer theranostics (20 papers), Nanoparticle-Based Drug Delivery (17 papers) and RNA Interference and Gene Delivery (12 papers). Jingjing Sun collaborates with scholars based in China, United States and Portugal. Jingjing Sun's co-authors include Song Li, Padmanee Sharma, James P. Allison, Yixian Huang, Qiwei Qin, Youhua Huang, Xiaohong Huang, Jieni Xu, Yichao Chen and Xin Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Jingjing Sun

66 papers receiving 2.7k citations

Hit Papers

VISTA is an inhibitory immune checkpoint that is increase... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
    2017 455 citations James P. Allison, Jingjing Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Sun China 30 1.0k 935 929 642 365 75 2.7k
Khaled Seidi Iran 26 553 0.5× 734 0.8× 1.2k 1.3× 696 1.1× 447 1.2× 37 2.8k
Ghasem Ghalamfarsa Iran 30 794 0.8× 708 0.8× 1.0k 1.1× 445 0.7× 412 1.1× 64 2.6k
Hee Dong Han South Korea 33 691 0.7× 496 0.5× 1.4k 1.5× 543 0.8× 623 1.7× 86 2.9k
Ommoleila Molavi Iran 27 557 0.5× 507 0.5× 1.3k 1.4× 373 0.6× 541 1.5× 73 2.7k
Tae Woo Kim South Korea 30 807 0.8× 710 0.8× 1.2k 1.3× 256 0.4× 228 0.6× 65 2.3k
Hong Yuan China 23 642 0.6× 327 0.3× 1.3k 1.4× 382 0.6× 435 1.2× 43 2.5k
Asmita Das India 19 446 0.4× 575 0.6× 701 0.8× 297 0.5× 137 0.4× 58 2.0k
Xun Sun China 30 543 0.5× 283 0.3× 1.4k 1.5× 1.0k 1.6× 691 1.9× 60 2.9k

Countries citing papers authored by Jingjing Sun

Since Specialization
Citations

This map shows the geographic impact of Jingjing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Sun more than expected).

Fields of papers citing papers by Jingjing Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Sun. The network helps show where Jingjing Sun may publish in the future.

Co-authorship network of co-authors of Jingjing Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Sun. A scholar is included among the top collaborators of Jingjing Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Sun. Jingjing Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jingjing, et al.. (2025). Lodge-Unet: a dual-frequency feature fusion network with boundary-aware optimization for wheat lodging detection via autonomous harvesters. Computers and Electronics in Agriculture. 238. 110769–110769.
2.
Lin, Junyi, et al.. (2025). Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy. Pharmaceutics. 17(10). 1322–1322.
3.
Lin, Junyi, et al.. (2025). Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. PubMed. 6(3). 368–386. 1 indexed citations
4.
Huang, Haozhe, Yixian Huang, Beihong Ji, et al.. (2025). Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance. Nature Communications. 16(1). 4176–4176. 3 indexed citations
5.
Sun, Jingjing, et al.. (2025). Serum Inflammatory Factors Levels and Risk of Myasthenia Gravis: A Bidirectional Mendelian Randomization Study. Molecular Neurobiology. 62(6). 7738–7746.
6.
Zhang, Ziqian, Zhangyi Luo, Haozhe Huang, et al.. (2024). YAP/TAZ Inhibitor-Based Drug Delivery System for Selective Tumor Accumulation and Cancer Combination Therapy. Biomacromolecules. 26(1). 266–278. 1 indexed citations
7.
Zhang, Qun, Xiaoxiao Wang, Fen Li, et al.. (2024). Cell-free Nucleic Acid as Promising Diagnostic Biomarkers for Gastric Cancer: a Systematic Review. Journal of Cancer. 15(10). 2900–2912.
8.
Zhou, Zheng, Shuai Zhu, Wenxiang Zhu, et al.. (2024). A biocompatible pea protein isolate-derived bioink for 3D bioprinting and tissue engineering. Journal of Materials Chemistry B. 12(27). 6716–6723. 4 indexed citations
9.
Luo, Zhangyi, Yixian Huang, Neelu Batra, et al.. (2024). Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature Communications. 15(1). 255–255. 30 indexed citations
10.
11.
12.
13.
Moharil, Pearl, Zhuoya Wan, Jiang Li, et al.. (2021). Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages. Acta Pharmaceutica Sinica B. 12(3). 1148–1162. 53 indexed citations
14.
Chen, Yuang, Yixian Huang, Haozhe Huang, et al.. (2021). Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination. Molecular Therapy — Nucleic Acids. 26. 594–602. 11 indexed citations
15.
Wan, Zhuoya, Runzi Sun, Yang‐Wuyue Liu, et al.. (2021). Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science Advances. 7(50). eabj4226–eabj4226. 23 indexed citations
16.
Sun, Jingjing, Zhuoya Wan, Jieni Xu, et al.. (2020). Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer. Biomaterials. 269. 120629–120629. 41 indexed citations
17.
Sun, Jingjing, Zhuoya Wan, Yichao Chen, et al.. (2020). Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. Acta Biomaterialia. 106. 289–300. 41 indexed citations
18.
Chen, Yichao, Jingjing Sun, Yixian Huang, et al.. (2018). Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis. Nanomedicine Nanotechnology Biology and Medicine. 15(1). 129–141. 28 indexed citations
19.
Tang, Derek Ng, Yu Shen, Jingjing Sun, et al.. (2013). Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy. Cancer Immunology Research. 1(4). 229–234. 146 indexed citations
20.
Sun, Jingjing. (2008). Jacquard control system for three-level loop carpet tufting machine. Textile Research Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khaled Seidi Breakdown of academic impact, for papers by Ghasem Ghalamfarsa Breakdown of academic impact, for papers by Hee Dong Han Breakdown of academic impact, for papers by Ommoleila Molavi Breakdown of academic impact, for papers by Tae Woo Kim Breakdown of academic impact, for papers by Hong Yuan Breakdown of academic impact, for papers by Asmita Das Breakdown of academic impact, for papers by Xun Sun
Rankless by CCL
2026